Mohammad Heidaran, PhD

NIH trained scientist with in depth industrial product development, managerial experience and FDA regulatory expertise in cell & gene therapy and tissue engineering. Author of more than 50 original research articles and holder of 22 issued patents and 44 additional pending patents. Founder and first Chair of Gordon Research Conference on Signal Transduction by Engineered ECM. Specialties: Regulatory Science, Cell Therapy and Tissue Engineering Product Manufacturing, Stem Cell Biology, Extracellular Matrix Biology, Hematopoietic and MSC Biology, Large Scale Cell Manufacturing, Three-Dimensional Culture System, Cancer Biology, and Signal Transduction.